Literature DB >> 318214

Penetration of cefoxitin into human cerebrospinal fluid: comparison with cefamandole, ampicillin, and penicillin.

C Liu1, D R Hinthorn, G R Hodges, J L Harms, G Couchonnal, D L Dworzack.   

Abstract

Single, intravenously administered doses of cefoxitin and cefamandole did not penetrate into cerebrospinal fluid of normal humans. Multiple-dose administration with or without probenecid facilitated penetration of both antibiotics into the cerebrospinal fluid. Preliminary data showed that cefoxitin penetrated into cerebrospinal fluid of patients with inflamed meninges even when administered in a single dose without probenecid. However, the concentrations of cefoxitin in the cerebrospinal fluid of the individuals studied were not within the therapeutic range.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 318214     DOI: 10.1093/clinids/1.1.127

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  9 in total

1.  Cefoxitin: intravenous pharmacokinetics and intramuscular bioavailability in kwashiorkor.

Authors:  N Buchanan; Y Mithal; M Witcomb
Journal:  Br J Clin Pharmacol       Date:  1980-06       Impact factor: 4.335

Review 2.  Cephalosporins in the treatment of meningitis.

Authors:  H C Neu
Journal:  Drugs       Date:  1987       Impact factor: 9.546

Review 3.  Cephalosporin-probenecid drug interactions.

Authors:  G R Brown
Journal:  Clin Pharmacokinet       Date:  1993-04       Impact factor: 6.447

4.  Treatment of experimental Haemophilus influenzae type b meningitis with 1-oxa-beta-lactam (LY127935).

Authors:  C S Cordera; R S Pekarek
Journal:  Antimicrob Agents Chemother       Date:  1980-02       Impact factor: 5.191

5.  Penetration of cefoxitin into cerebrospinal fluid of infants and children with bacterial meningitis.

Authors:  W E Feldman; S Moffitt; N S Manning
Journal:  Antimicrob Agents Chemother       Date:  1982-03       Impact factor: 5.191

6.  Cefotaxime in treatment of meningitis and ventriculitis? Evaluation of drug concentrations in human cerebrospinal fluid.

Authors:  O Brückner; H Collmann; H G Hoffmann
Journal:  Intensive Care Med       Date:  1982-01       Impact factor: 17.440

7.  Cefoxitin concentrations in the cerebrospinal fluids of patients with meningitis.

Authors:  G Humbert; A Leroy; J P Rogez; C Cherubin
Journal:  Antimicrob Agents Chemother       Date:  1980-04       Impact factor: 5.191

8.  Effect of orally administered probenecid on the pharmacokinetics of cefoxitin.

Authors:  P H Vlasses; A M Holbrook; J J Schrogie; J D Rogers; R K Ferguson; W B Abrams
Journal:  Antimicrob Agents Chemother       Date:  1980-05       Impact factor: 5.191

9.  Cefoxitin penetration into cerebrospinal fluid in patients with purulent meningitis.

Authors:  P A Galvao; A V Lomar; W Francisco; C V de Godoy; R Norrby
Journal:  Antimicrob Agents Chemother       Date:  1980-04       Impact factor: 5.191

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.